Corrigendum to abstract “Bone mineral density change in type 1 Gaucher disease adults given velaglucerase alfa for 2 years” [Molecular Genetics and Metabolism 108/2 (2013) S101]

Corrigendum to abstract “Bone mineral density change in type 1 Gaucher disease adults given velaglucerase alfa for 2 years” [Molecular Genetics and Metabolism 108/2 (2013) S101] Ari Zimran⁎, Pilar Giraldo, David Zahrieh, Eric Crombez, Gabriel Cohn, Deborah Elstein on behalf of the TKT032 and HGT-GCB-039 study investigators a Gaucher Clinic, Shaare Zedek Medical Center and Hebrew University-Hadassah Medical School, Jerusalem, Israel b CIBERER, Zaragoza, Spain c Hospital Universitario Miguel Servet, Zaragoza, Spain d Shire Human Genetic Therapies, Inc., Lexington, MA, USA